Original Research
Published on 10 Feb 2025
The development and evaluation of a tublysine-based antibody-drug conjugate with enhanced tumor therapeutic efficacy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1532104
- 5,239 views
- 1 citation


